missing translation for 'onlineSavingsMsg'
Learn More
Learn More
Human CD82/Kai-1 Antibody, R&D Systems™

Mouse Monoclonal Antibody has been used in 2 publications
Brand: R&D Systems MAB4616-SP
Dieser Artikel kann nicht zurückgegeben werden.
Rückgaberichtlinie anzeigen
Beschreibung
CD82/Kai-1 Monoclonal specifically detects CD82/Kai-1 in Human samples. It is validated for Flow Cytometry, CyTOF-ready.
Spezifikation
| CD82/Kai-1 | |
| Monoclonal | |
| LYOPH | |
| Flow Cytometry 2.5 ug/10^6 cells, CyTOF-ready | |
| AAH01821 | |
| CD82 | |
| NS0 mouse myeloma cell line transfected with human CD82/Kai-1 Met1-Tyr267 Accession # AAH01821 | |
| 25 μg | |
| Primary | |
| Detects human CD82/Kai-1. Stains human CD82/Kai-1 transfectants but not irrelevant transfectants. | |
| Human | |
| Purified |
| Flow Cytometry, CyTOF | |
| 423524 | |
| Unconjugated | |
| Lyophilized from a 0.2 μm filtered solution in PBS with Trehalose. *Small pack size (SP) is supplied as a 0.2 μm filtered solution in PBS. with No Preservative | |
| CD82, CD82 antigenC33, CD82 molecule, IA4, IA4C33 antigen, Inducible membrane protein R2, KAI1, KAI1GR15, kangai 1 (suppression of tumorigenicity 6, prostate; CD82 antigen (R2 leukocyteantigen, antigen detected by monoclonal and IA4)), Metastasis suppressor Kangai-1, R2, SAR2, SAR2tetraspanin-27, ST6, ST6tspan-27, Suppressor of tumorigenicity 6 protein, Tetraspanin-27, Tspan-27, TSPAN27, TSPAN274F9 | |
| Mouse | |
| Protein A or G purified from hybridoma culture supernatant | |
| RUO | |
| 3732 | |
| Reconstitute at 0.5 mg/mL in sterile PBS. | |
| Use a manual defrost freezer and avoid repeated freeze-thaw cycles. 12 months from date of receipt, -20 to -70 degreesC as supplied. 1 month, 2 to 8 degreesC under sterile conditions after reconstitution. 6 months, -20 to -70 degreesC under sterile conditions after reconstitution. | |
| IgG1 |
Berichtigung von Produktinhalten
Bitte geben Sie uns Ihr Feedback zu den Produktinhalten, indem Sie das folgende Formular ausfüllen.
Name des Produkts
For Research Use Only
Haben Sie Verbesserungsvorschläge?Übermitteln Sie eine inhaltliche Korrektur